Never miss a Delaware County story!
ArriVent Biopharma in Newtown Square plans to initiate a public stock offering to raise between $137.5 million and $160 million for the development and…
Two Delaware County life science firms are leading the way this year in equity financing.
A cancer treatment drug being developed by ArriVent Biopharma in…
A Newtown Square biopharmaceutical company, ArriVent, has raised $110 million in a private stock sale to bring cancer medicines approved in China to the U…
There’s a new biopharmaceutical company in town, specifically, in Newtown Square, writes John George for the Philadelphia Business Journal.
ArriVent Biopharma of Newtown Square…
Before we send you to this site, please subscribe to our daily newsletter.